Possible scenario
Sale Talks Revive
25% Chance
Instead of a conventional spinoff, J&J reopens discussions with Apollo or another financial sponsor for a sale or structured carve-out of the orthopedics unit. A sale could accelerate portfolio simplification and reduce separation risk, but valuation will determine the market reaction.
Secondary impacts
- Healthcare +0.3%
- Finance +0.1%
Tickers
- JNJ+3.3%
- APO+0.5%
- ZBH+0.1%
Portfolio impact
S&P 500+0.1%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.